{"parse":{"title":"Federation of European Pharmacological Societies","pageid":38944750,"revid":802912121,"text":{"*":"<div class=\"mw-parser-output\"><p>The <b>Federation of European Pharmacological Societies</b> (EPHAR)<sup id=\"cite_ref-EPHAR_1-0\" class=\"reference\"><a href=\"#cite_note-EPHAR-1\">&#91;1&#93;</a></sup> is a non-profit voluntary association established to advance research and education in the science of <a href=\"/wiki/Pharmacology\" title=\"Pharmacology\">pharmacology</a> and to promote co-operation between national/regional pharmacological societies in <a href=\"/wiki/Europe\" title=\"Europe\">Europe</a> and surrounding countries. It is an <a href=\"/wiki/Umbrella_organization\" title=\"Umbrella organization\">umbrella organization</a> of currently 27 national societies for pharmacology and represents over 10,000 individual pharmacologists in Europe. Moreover it seeks to co-operate with other international organizations, especially the <a href=\"/wiki/International_Union_of_Basic_and_Clinical_Pharmacology\" title=\"International Union of Basic and Clinical Pharmacology\">International Union of Basic and Clinical Pharmacology</a> (IUPHAR) of which EPHAR is an associate member.<sup id=\"cite_ref-2\" class=\"reference\"><a href=\"#cite_note-2\">&#91;2&#93;</a></sup>\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#History\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">History</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#Activities\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Activities</span></a></li>\n<li class=\"toclevel-1 tocsection-3\"><a href=\"#Executive_committees\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Executive committees</span></a></li>\n<li class=\"toclevel-1 tocsection-4\"><a href=\"#Composition\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">Composition</span></a></li>\n<li class=\"toclevel-1 tocsection-5\"><a href=\"#Future_directions\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">Future directions</span></a></li>\n<li class=\"toclevel-1 tocsection-6\"><a href=\"#External_links\"><span class=\"tocnumber\">6</span> <span class=\"toctext\">External links</span></a></li>\n<li class=\"toclevel-1 tocsection-7\"><a href=\"#References\"><span class=\"tocnumber\">7</span> <span class=\"toctext\">References</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"History\">History</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Federation_of_European_Pharmacological_Societies&amp;action=edit&amp;section=1\" title=\"Edit section: History\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The efforts in the 1990s to unite European economical and political forces had found their counterpart in formation of European scientific federations. One of those scientific federations is EPHAR that was founded at the XIth International Congress of Pharmacology in <a href=\"/wiki/Amsterdam\" title=\"Amsterdam\">Amsterdam</a> (The Netherlands) in 1990. The establishment of the federation was prepared by a steering committee formed in 1988 under the initiative of Rodolfo Paoletti. The steering committee, headed by B\u00f6rje Uvn\u00e4s, consisted of six members: Alasdair Breckenridge (UK), Flaminio Cattabeni (Italy), Gilles Fillion (France), Ove A. Nedergaard (Denmark), Rodolfo Paoletti (Italy), Hasso Scholz (Germany), B\u00f6rje Uvn\u00e4s (Sweden). EPHAR was recognized as an affiliate member of IUPHAR in 1994. Since 1990, the Federation has sponsored important scientific events. In particular, EPHAR has contributed in the organization of residential courses with a restricted number of participants (\"Molecular Biology in Pharmacology\", Milan, 1990; \"Neuroimmunomodulation in Pharmacology\", Paris, 1992; \"Electrophysiology in Pharmacology\", London, 1993).<sup id=\"cite_ref-EPHAR_History_3-0\" class=\"reference\"><a href=\"#cite_note-EPHAR_History-3\">&#91;3&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Activities\">Activities</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Federation_of_European_Pharmacological_Societies&amp;action=edit&amp;section=2\" title=\"Edit section: Activities\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Pharmacology has developed into a multifaceted discipline extending from <a href=\"/wiki/Molecular_biology\" title=\"Molecular biology\">molecular biology</a> at the one end to <a href=\"/wiki/Clinical_pharmacology\" title=\"Clinical pharmacology\">clinical pharmacology</a> at the other.<sup id=\"cite_ref-F\u00f6rstermann_and_Griesbacher_2012_4-0\" class=\"reference\"><a href=\"#cite_note-F\u00f6rstermann_and_Griesbacher_2012-4\">&#91;4&#93;</a></sup> The necessity of collaborative efforts within all branches of <a href=\"/wiki/Biology\" title=\"Biology\">biological sciences</a>, in the development and analysis of new <a href=\"/wiki/Drug\" title=\"Drug\">drugs</a>, is the driving force of the activities of EPHAR. One challenge of this federation is the creation of new generations of pharmacologists with an analytical and broadminded attitude towards important aspects of modern medical biological sciences.<sup id=\"cite_ref-F\u00f6rstermann_2012_5-0\" class=\"reference\"><a href=\"#cite_note-F\u00f6rstermann_2012-5\">&#91;5&#93;</a></sup>\n</p><p>The Federation seeks to achieve its objects by arranging instructional courses and training programs in matters connected with pharmacology, facilitating the exchange of scientific information between European pharmacologists (by encouraging the holding of joint meetings between European member societies), disseminating information and encouraging the participation to important activities organized by member societies. This will include the production of a calendar of the National and joint meetings of each European Society.\n</p><p>Another important goal of the Federation is establishing common standards for basic courses in pharmacology, and fixing minimal standards for a European Pharmacologist Certificate.\n</p><p>The scientific dissemination is a fundamental step in progress and advance in research and education. For this reason, the most important scientific events established by the Federation are the EPHAR Congresses. They include plenary lectures, symposia, round tables, oral and poster communications devoted to the most recent advances in pharmacology and related sciences and therefore represented the adequate forum for discussing preclinical, clinical and therapeutic data. Particular emphasis was given to the impact of <a href=\"/wiki/Biotechnology\" title=\"Biotechnology\">biotechnologies</a> on <a href=\"/wiki/Drug_development\" title=\"Drug development\">drug development</a> and to the identification of novel pharmacological approaches to <a href=\"/wiki/Cure\" title=\"Cure\">incurable</a> <a href=\"/wiki/Disease\" title=\"Disease\">diseases</a>. Sessions were also held on drug development, strategies for <a href=\"/wiki/Funding_of_science\" title=\"Funding of science\">research funding</a> and training of pharmacologists.\n</p><p>The EPHAR Congresses that have taken place since EPHAR\u2019s foundation are:<sup id=\"cite_ref-F\u00f6rstermann_2012_5-1\" class=\"reference\"><a href=\"#cite_note-F\u00f6rstermann_2012-5\">&#91;5&#93;</a></sup>\n</p>\n<ul><li>1st EPHAR Congress: <a href=\"/wiki/Milan\" title=\"Milan\">Milan</a> (Italy), 16\u201319 June 1995</li>\n<li>2nd EPHAR Congress: <a href=\"/wiki/Budapest\" title=\"Budapest\">Budapest</a> (Hungary), 3\u20137 July 1999</li>\n<li>3rd EPHAR Congress: <a href=\"/wiki/Lyon\" title=\"Lyon\">Lyon</a> (France), 6\u20139 July 2001</li>\n<li>4th EPHAR Congress: <a href=\"/wiki/Porto\" title=\"Porto\">Porto</a> (Portugal), 14\u201317 July 2004</li>\n<li>5th EPHAR Congress: <a href=\"/wiki/Manchester\" title=\"Manchester\">Manchester</a> (UK), 13\u201317 July 2008</li>\n<li>6th EPHAR Congress: <a href=\"/wiki/Granada\" title=\"Granada\">Granada</a> (Spain), 17\u201320 July 2012</li>\n<li>7th EPHAR Congress: <a href=\"/wiki/Istanbul\" title=\"Istanbul\">Istanbul</a> (Turkey), 26\u201330 June 2016</li></ul>\n<p>EPHAR supports activities, organized by its member societies that are intended to improve the cooperation among European pharmacologists. They are traditionally\n</p>\n<ul><li>EPHAR Lectures</li>\n<li>EPHAR Symposia</li>\n<li>EPHAR Instructional Courses</li></ul>\n<p>One of these activities per year, for each country, is promoted by EPHAR. Calls for applications for these EPHAR-supported activities and the guidelines for these events are announced annually.\n</p><p>Moreover on special occasions EPHAR gives prizes to European young investigators in the field of pharmacology, the EPHAR Young Investigators Awards. So far, the following awards were given:\n</p>\n<ul><li>EPHAR Young Investigators Awards 2010</li>\n<li>EPHAR Young Investigators Awards 2012</li>\n<li>EPHAR Young Investigators Awards 2014</li></ul>\n<h2><span class=\"mw-headline\" id=\"Executive_committees\">Executive committees</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Federation_of_European_Pharmacological_Societies&amp;action=edit&amp;section=3\" title=\"Edit section: Executive committees\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The term of the EPHAR Executive Committees is four years.\n</p><p>The present (2016\u20132020) Executive Committee is composed by the following members:<sup id=\"cite_ref-EPHAR_Committee_6-0\" class=\"reference\"><a href=\"#cite_note-EPHAR_Committee-6\">&#91;6&#93;</a></sup>\n</p>\n<ul><li>President (2016\u20132018): Robin Hiley (Department of Pharmacology, <a href=\"/wiki/University_of_Cambridge\" title=\"University of Cambridge\">University of Cambridge</a>, UK).</li>\n<li>President Elect: Mojca Kr\u017ean (Department of Pharmacology and Experimental Toxicology, Medical Faculty, <a href=\"/wiki/University_of_Ljubljana\" title=\"University of Ljubljana\">University of Ljubljana</a>, Ljubljana, Slovenia).</li>\n<li>Treasurer: Giuseppe Cirino (Department of Pharmacy, <a href=\"/wiki/University_of_Naples_Federico_II\" title=\"University of Naples Federico II\">University of Naples Federico II</a>, Italy).</li>\n<li>Secretary General: Andreas Papapetropoulos (Faculty of Pharmacy, School of Health Sciences, <a href=\"/wiki/National_and_Kapodistrian_University_of_Athens\" title=\"National and Kapodistrian University of Athens\">National and Kapodistrian University of Athens</a>, Greece).</li>\n<li>Markus Forsberg (School of Pharmacy <a href=\"/wiki/University_of_Eastern_Finland\" title=\"University of Eastern Finland\">University of Eastern Finland</a>, Finland).</li>\n<li>Antoinette Maassen-van den Brink (Department of Pharmacology, <a href=\"/wiki/Erasmus_University_Rotterdam\" title=\"Erasmus University Rotterdam\">Erasmus University Rotterdam</a>, Netherlands).</li>\n<li>Mar\u00eda Jes\u00fas Sanz Ferrando (Department of Pharmacology, <a href=\"/wiki/University_of_Valencia\" title=\"University of Valencia\">University of Valencia</a>, Spain).</li>\n<li>Ond\u0159ej Slana\u0159 (Department of Pharmacology, 1st Medical Faculty, <a href=\"/wiki/Charles_University\" title=\"Charles University\">Charles University</a>, Prague, Czech Republic).</li>\n<li>Markus Zeitlinger (Department of Clinical Pharmacology, <a href=\"/wiki/Medical_University_of_Vienna\" title=\"Medical University of Vienna\">Medical University of Vienna</a>, Austria).</li></ul>\n<p>Past Presidents were:\n</p>\n<ul><li>2014\u20132016: Thomas Griesbacher (<a href=\"/wiki/Graz\" title=\"Graz\">Graz</a>, Austria)</li>\n<li>2012\u20132014: Filippo Drago (<a href=\"/wiki/Catania\" title=\"Catania\">Catania</a>, Italy)</li>\n<li>2010\u20132012: <a href=\"/wiki/Ulrich_F%C3%B6rstermann\" title=\"Ulrich F\u00f6rstermann\">Ulrich F\u00f6rstermann</a> (<a href=\"/wiki/Mainz\" title=\"Mainz\">Mainz</a>, Germany)</li>\n<li>2008\u20132010: Eeva Moilanen (<a href=\"/wiki/Tampere\" title=\"Tampere\">Tampere</a>, Finland)</li>\n<li>2006\u20132008: Arthur Weston (<a href=\"/wiki/Manchester\" title=\"Manchester\">Manchester</a>, UK)</li>\n<li>2004\u20132006: Manfred G\u00f6thert (<a href=\"/wiki/Bonn\" title=\"Bonn\">Bonn</a>, Germany)</li>\n<li>2002\u20132004: Alan W. Cuthbert (<a href=\"/wiki/Cambridge\" title=\"Cambridge\">Cambridge</a>, UK)</li>\n<li>1997\u20132002: Flaminio Cattabeni (<a href=\"/wiki/Milan\" title=\"Milan\">Milan</a>, Italy)</li>\n<li>1990\u20131997: Rodolfo Paoletti (Milan, Italy)</li></ul>\n<h2><span class=\"mw-headline\" id=\"Composition\">Composition</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Federation_of_European_Pharmacological_Societies&amp;action=edit&amp;section=4\" title=\"Edit section: Composition\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The National Societies members of EPHAR are (in alphabetical order):\n\u2022\tAustrian Pharmacological Society (\u00d6sterreichische Pharmakologische Gesellschaft) APHAR.\n\u2022\tBelgian Society of Fundamental and Clinical Physiology and Pharmacology. Soci\u00e9t\u00e9 Belge de Physiologie et de Pharmacologie Fondamentales et Cliniques. Belgisch Genootschap voor Fundamentele en Klinische Fysiologie en Farmacologie. \n\u2022\tAssociation of Pharmacologists of the Federation of Bosnia and Herzegovina. Udru\u017eenje Farmakologa Federacije Bosne i Hercegovine.\n\u2022\t<a href=\"/wiki/British_Pharmacological_Society\" title=\"British Pharmacological Society\">British Pharmacological Society</a> (BPS).\n\u2022\tBulgarian Pharmacological Society.\n\u2022\tCroatian Pharmacological Society. Hrvatsko Dru\u0161tvo Farmakologa. (HDF). \n\u2022\tCzech Society for Experimental and Clinical Pharmacology and Toxicology. \u010cesk\u00e1 Spole\u010dnost pro Experiment\u00e1ln\u00ed a Klinickou Farmakologii a Toxicologii (\u010cSEKFT). \n\u2022\tDanish Society for Pharmacology, Toxicology and Medicinal Chemistry. Dansk Selskab for Farmakologi, Toksikologi og Medicinalkemi (DSFTM). \n\u2022\tDutch Pharmacological Society. Nederlands Vereniging voor Farmacologie (NVF)\n\u2022\tFinnish Pharmacological Society. Suomen Farmakologiyhdistys. (SFY). \n\u2022\tFrench Society of Pharmacology and Therapeutics. Soci\u00e9t\u00e9 Fran\u00e7aise de Pharmacologie et de Th\u00e9rapeutique. (SFPT).\n\u2022\tGerman Society of Pharmacology. Deutsche Gesellschaft f\u00fcr Pharmakologie. (DGP). \n\u2022\tHellenic (Greek) Society of Basic and Clinical Pharmacology. \u0395\u03bb\u03bb\u03b7\u03bd\u03b9\u03ba\u03ae \u0395\u03c4\u03b1\u03b9\u03c1\u03b5\u03af\u03b1 \u03a6\u03b1\u03c1\u03bc\u03b1\u03ba\u03b1\u03bb\u03bf\u03b3\u03af\u03b1\u03c2 (Ellinik\u00ed Etaire\u00eda Pharmakolog\u00edas). \n\u2022\tHungarian Society for Experimental and Clinical Pharmacology. Magyar Kis\u00e9rletes \u00e9s Klinikai Farmak\u00f3logiai T\u00e1rsas\u00e1g (MFT).\n\u2022\tIsrael Society for Physiology and Pharmacology (ISPP).\n\u2022\tSociet\u00e0 Italiana di Farmacologia (SIF). \n\u2022\tLatvian Society of Pharmacology. Latvijas Farmakolo\u0123ijas biedr\u012bba. (LFB).\n\u2022\tNorwegian Society for Pharmacology and Toxicology. Norsk Selskap for Farmakologi og Toksikologi. (NSFT). \n\u2022\tPharmacology Society of Malta.\n\u2022\tPolish Pharmacological Society. Polskie Towarzystwo Farmakologiczne. (PTST). \n\u2022\tPortuguese Pharmacological Society. Sociedade Portuguesa de Farmacologia (SPF).\n\u2022\tRussian Scientific Society of Pharmacology.\n\u2022\tSerbian Pharmacological Society. \u0421\u0440\u043f\u0441\u043a\u043e \u0424\u0430\u0440\u043c\u0430\u043a\u043e\u043b\u043e\u0448\u043a\u043e \u0414\u0440\u0443\u0448\u0442\u0432\u043e / Srpsko Farmakolo\u0161ko Dru\u0161tvo (\u0421\u0424\u0414 / SFD). \n\u2022\tSlovak Pharmacological Society. Slovensk\u00e1 Farmakologick\u00e1 Spolo\u010dnos\u0165 (SFaS). \n\u2022\tSlovenian Pharmacological Society. Slovensko Dru\u0161tvo Farmakologov. (SDF).\n\u2022\tSpanish Society of Pharmacology. Sociedad Espa\u00f1ola de Farmacolog\u00eda (SEF).\n\u2022\tSwedish Society for Pharmacology, Clinical Pharmacology and Therapeutics. Sektionen f\u00f6r L\u00e4kemedelsl\u00e4ra.\n\u2022\tSwiss Society of Pharmacology and Toxicology. Soci\u00e9t\u00e9 Suisse de Pharmacologie et de Toxicologie/ Schweizerische Gesellschaft f\u00fcr Pharmakologie und Toxikologie (SSPT/SGPT). \n\u2022\t<a rel=\"nofollow\" class=\"external text\" href=\"http://www.tfd.org.tr\">Turkish Pharmacological Society. T\u00fcrk Farmakoloji Derne\u011fi</a> (TFD).\n</p>\n<h2><span class=\"mw-headline\" id=\"Future_directions\">Future directions</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Federation_of_European_Pharmacological_Societies&amp;action=edit&amp;section=5\" title=\"Edit section: Future directions\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The (2012\u22122014) EPHAR president, Filippo Drago, has announced the institution of \u201cEPHAR ambassadors\u201d, in order to reach countries that are not yet members of EPHAR (in particular <a href=\"/wiki/Azerbaijan\" title=\"Azerbaijan\">Azerbaijan</a>, <a href=\"/wiki/Estonia\" title=\"Estonia\">Estonia</a>, <a href=\"/wiki/Israel\" title=\"Israel\">Israel</a> and <a href=\"/wiki/Belarus\" title=\"Belarus\">Belarus</a>). These countries may be possibly not organized in national pharmacological societies, and that could make them hard to reach. The \u201cEPHAR ambassador\u201d will support the spreading of knowledge of EPHAR activities, hiring high quality applicants to congresses, lectures and seminars. Another important ongoing project of EPHAR is about changes in the bylaws, that were presented and accepted at the General Assembly to be held in <a href=\"/wiki/Cape_Town\" title=\"Cape Town\">Cape Town</a> in 2014.\n</p>\n<h2><span class=\"mw-headline\" id=\"External_links\">External links</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Federation_of_European_Pharmacological_Societies&amp;action=edit&amp;section=6\" title=\"Edit section: External links\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>EPHAR website: <a rel=\"nofollow\" class=\"external free\" href=\"http://www.ephar.org/\">http://www.ephar.org/</a>\n</p><p>The internet sites for each European pharmacological society, member of EPHAR, are hereby listed:\n</p><p>\u2022\tAustria: <a rel=\"nofollow\" class=\"external free\" href=\"http://www.aphar.at/\">http://www.aphar.at/</a>\n</p><p>\u2022\tBelgium: <a rel=\"nofollow\" class=\"external free\" href=\"http://users.ugent.be/~jvdvoord/physiology&amp;pharmacology/index.htm\">http://users.ugent.be/~jvdvoord/physiology&amp;pharmacology/index.htm</a>\n</p><p>\u2022\tCroatia: <a rel=\"nofollow\" class=\"external free\" href=\"http://pharma.mef.hr/\">http://pharma.mef.hr/</a>\n</p><p>\u2022 \tCzech Republic: <a rel=\"nofollow\" class=\"external free\" href=\"http://farmspol.cls.cz/\">http://farmspol.cls.cz/</a>\n</p><p>\u2022\tDenmark <a rel=\"nofollow\" class=\"external free\" href=\"http://www.dsftm.dk/index.php/en/\">http://www.dsftm.dk/index.php/en/</a>\n</p><p>\u2022\tNetherlands: <a rel=\"nofollow\" class=\"external free\" href=\"http://www.nvfarmaco.nl/\">http://www.nvfarmaco.nl/</a>\n</p><p>\u2022\tFinland: <a rel=\"nofollow\" class=\"external free\" href=\"http://www.sfy.fi/\">http://www.sfy.fi/</a>\n</p><p>\u2022\tFrance: <a rel=\"nofollow\" class=\"external free\" href=\"http://www.pharmacol-fr.org/\">http://www.pharmacol-fr.org/</a>\n</p><p>\u2022\tGermany: <a rel=\"nofollow\" class=\"external free\" href=\"http://www.dg-pharmakologie.de/\">http://www.dg-pharmakologie.de/</a>\n</p><p>\u2022\tGreece: <a rel=\"nofollow\" class=\"external free\" href=\"http://gsp.med.auth.gr/\">http://gsp.med.auth.gr/</a>\n</p><p>\u2022\tHungary: <a rel=\"nofollow\" class=\"external free\" href=\"http://www.mapharm.hu/\">http://www.mapharm.hu/</a>\n</p><p>\u2022\tItaly: <a rel=\"nofollow\" class=\"external free\" href=\"http://www.sifweb.org/\">http://www.sifweb.org/</a>\n</p><p>\u2022\tNorway: <a rel=\"nofollow\" class=\"external free\" href=\"http://www.nsft.net/\">http://www.nsft.net/</a>\n</p><p>\u2022\tPoland: <a rel=\"nofollow\" class=\"external free\" href=\"http://www.ptf.info.pl/\">http://www.ptf.info.pl/</a>\n</p><p>\u2022\tSerbia: <a rel=\"nofollow\" class=\"external free\" href=\"http://www.sfarmd.org/\">http://www.sfarmd.org/</a>\n</p><p>\u2022\tSlovakia: <a rel=\"nofollow\" class=\"external free\" href=\"http://www.sfarm.sk/\">http://www.sfarm.sk/</a>\n</p><p>\u2022\tSpain: <a rel=\"nofollow\" class=\"external free\" href=\"http://www.socesfar.com/\">http://www.socesfar.com/</a>\n</p><p>\u2022\tSweden <a rel=\"nofollow\" class=\"external free\" href=\"http://www.lakemedelslara.se/\">http://www.lakemedelslara.se/</a>\n</p><p>\u2022\tSwitzerland: <a rel=\"nofollow\" class=\"external free\" href=\"http://www.swisspharmtox.ch/\">http://www.swisspharmtox.ch/</a>\n</p><p>\u2022\tTurkey: <a rel=\"nofollow\" class=\"external free\" href=\"http://www.tfd.org.tr/\">http://www.tfd.org.tr/</a>\n</p><p>\u2022\tUnited Kingdom: <a rel=\"nofollow\" class=\"external free\" href=\"https://web.archive.org/web/20130410071823/http://www.bps.ac.uk/view/index.html\">https://web.archive.org/web/20130410071823/http://www.bps.ac.uk/view/index.html</a>\n</p>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Federation_of_European_Pharmacological_Societies&amp;action=edit&amp;section=7\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist\" style=\"list-style-type: decimal;\">\n<div class=\"mw-references-wrap\"><ol class=\"references\">\n<li id=\"cite_note-EPHAR-1\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-EPHAR_1-0\">^</a></b></span> <span class=\"reference-text\">\"<a rel=\"nofollow\" class=\"external text\" href=\"http://www.ephar.org/\">EPHAR The Federation of European Pharmacological Societies</a>\"</span>\n</li>\n<li id=\"cite_note-2\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-2\">^</a></b></span> <span class=\"reference-text\">\"<a rel=\"nofollow\" class=\"external text\" href=\"http://www.iuphar.org/members_assoc.html\">IUPHAR Associate Members</a>\"</span>\n</li>\n<li id=\"cite_note-EPHAR_History-3\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-EPHAR_History_3-0\">^</a></b></span> <span class=\"reference-text\">\"<a rel=\"nofollow\" class=\"external text\" href=\"http://www.ephar.org/federation.html\">History of EPHAR</a>\"</span>\n</li>\n<li id=\"cite_note-F\u00f6rstermann_and_Griesbacher_2012-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-F\u00f6rstermann_and_Griesbacher_2012_4-0\">^</a></b></span> <span class=\"reference-text\">U. F\u00f6rstermann and T. Griesbacher: \"<a rel=\"nofollow\" class=\"external text\" href=\"http://www.publicservice.co.uk/article.asp?publication=European%20Science%20and%20Technology&amp;id=572&amp;content_name=Health%20and%20Social%20Care&amp;article=20411\">The edge of glory</a>\". <i>Public Service Review: European Science &amp; Technology</i>, 2012, 15: pp.222\u2212223</span>\n</li>\n<li id=\"cite_note-F\u00f6rstermann_2012-5\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-F\u00f6rstermann_2012_5-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-F\u00f6rstermann_2012_5-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\">U. F\u00f6rstermann: \"<a rel=\"nofollow\" class=\"external text\" href=\"http://www.bps.ac.uk/SpringboardWebApp/userfiles/bps/file/Publications/July2012.pdf\">Pharmacology across Europe, a status report</a>\" <i>Pharmacology Matters</i>, 2012, vol.5(2), pp.6\u22129.</span>\n</li>\n<li id=\"cite_note-EPHAR_Committee-6\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-EPHAR_Committee_6-0\">^</a></b></span> <span class=\"reference-text\">\"<a rel=\"nofollow\" class=\"external text\" href=\"http://www.ephar.org/committee.html\">EPHAR Executive Committee</a>\"</span>\n</li>\n</ol></div></div>\n\n<!-- \nNewPP limit report\nParsed by mw2269\nCached time: 20180922030300\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.072 seconds\nReal time usage: 0.079 seconds\nPreprocessor visited node count: 196/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 428/2097152 bytes\nTemplate argument size: 112/2097152 bytes\nHighest expansion depth: 7/40\nExpensive parser function count: 0/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 3055/5000000 bytes\nNumber of Wikibase entities loaded: 0/400\nLua time usage: 0.005/10.000 seconds\nLua memory usage: 523 KB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%   37.195      1 Template:Reflist\n100.00%   37.195      1 -total\n  7.63%    2.840      1 Template:Main_other\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:38944750-0!canonical and timestamp 20180922030300 and revision id 802912121\n -->\n</div>"},"langlinks":[],"categories":[{"sortkey":"","*":"Pharmacological_societies"}],"links":[{"ns":0,"exists":"","*":"Amsterdam"},{"ns":0,"exists":"","*":"Azerbaijan"},{"ns":0,"exists":"","*":"Belarus"},{"ns":0,"exists":"","*":"Biology"},{"ns":0,"exists":"","*":"Biotechnology"},{"ns":0,"exists":"","*":"Bonn"},{"ns":0,"exists":"","*":"British Pharmacological Society"},{"ns":0,"exists":"","*":"Budapest"},{"ns":0,"exists":"","*":"Cambridge"},{"ns":0,"exists":"","*":"Cape Town"},{"ns":0,"exists":"","*":"Catania"},{"ns":0,"exists":"","*":"Charles University"},{"ns":0,"exists":"","*":"Clinical pharmacology"},{"ns":0,"exists":"","*":"Cure"},{"ns":0,"exists":"","*":"Disease"},{"ns":0,"exists":"","*":"Drug"},{"ns":0,"exists":"","*":"Drug development"},{"ns":0,"exists":"","*":"Erasmus University Rotterdam"},{"ns":0,"exists":"","*":"Estonia"},{"ns":0,"exists":"","*":"Europe"},{"ns":0,"exists":"","*":"Funding of science"},{"ns":0,"exists":"","*":"Granada"},{"ns":0,"exists":"","*":"Graz"},{"ns":0,"exists":"","*":"International Union of Basic and Clinical Pharmacology"},{"ns":0,"exists":"","*":"Israel"},{"ns":0,"exists":"","*":"Istanbul"},{"ns":0,"exists":"","*":"Lyon"},{"ns":0,"exists":"","*":"Mainz"},{"ns":0,"exists":"","*":"Manchester"},{"ns":0,"exists":"","*":"Medical University of Vienna"},{"ns":0,"exists":"","*":"Milan"},{"ns":0,"exists":"","*":"Molecular biology"},{"ns":0,"exists":"","*":"National and Kapodistrian University of Athens"},{"ns":0,"exists":"","*":"Pharmacology"},{"ns":0,"exists":"","*":"Porto"},{"ns":0,"exists":"","*":"Tampere"},{"ns":0,"exists":"","*":"Ulrich F\u00f6rstermann"},{"ns":0,"exists":"","*":"Umbrella organization"},{"ns":0,"exists":"","*":"University of Cambridge"},{"ns":0,"exists":"","*":"University of Eastern Finland"},{"ns":0,"exists":"","*":"University of Ljubljana"},{"ns":0,"exists":"","*":"University of Naples Federico II"},{"ns":0,"exists":"","*":"University of Valencia"}],"templates":[{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"}],"images":[],"externallinks":["http://www.ephar.org/","http://www.iuphar.org/members_assoc.html","http://www.ephar.org/federation.html","http://www.publicservice.co.uk/article.asp?publication=European%20Science%20and%20Technology&id=572&content_name=Health%20and%20Social%20Care&article=20411","http://www.bps.ac.uk/SpringboardWebApp/userfiles/bps/file/Publications/July2012.pdf","http://www.ephar.org/committee.html","http://www.tfd.org.tr","http://www.aphar.at/","http://users.ugent.be/~jvdvoord/physiology&pharmacology/index.htm","http://pharma.mef.hr/","http://farmspol.cls.cz/","http://www.dsftm.dk/index.php/en/","http://www.nvfarmaco.nl/","http://www.sfy.fi/","http://www.pharmacol-fr.org/","http://www.dg-pharmakologie.de/","http://gsp.med.auth.gr/","http://www.mapharm.hu/","http://www.sifweb.org/","http://www.nsft.net/","http://www.ptf.info.pl/","http://www.sfarmd.org/","http://www.sfarm.sk/","http://www.socesfar.com/","http://www.lakemedelslara.se/","http://www.swisspharmtox.ch/","http://www.tfd.org.tr/","https://web.archive.org/web/20130410071823/http://www.bps.ac.uk/view/index.html"],"sections":[{"toclevel":1,"level":"2","line":"History","number":"1","index":"1","fromtitle":"Federation_of_European_Pharmacological_Societies","byteoffset":842,"anchor":"History"},{"toclevel":1,"level":"2","line":"Activities","number":"2","index":"2","fromtitle":"Federation_of_European_Pharmacological_Societies","byteoffset":2050,"anchor":"Activities"},{"toclevel":1,"level":"2","line":"Executive committees","number":"3","index":"3","fromtitle":"Federation_of_European_Pharmacological_Societies","byteoffset":5954,"anchor":"Executive_committees"},{"toclevel":1,"level":"2","line":"Composition","number":"4","index":"4","fromtitle":"Federation_of_European_Pharmacological_Societies","byteoffset":7705,"anchor":"Composition"},{"toclevel":1,"level":"2","line":"Future directions","number":"5","index":"5","fromtitle":"Federation_of_European_Pharmacological_Societies","byteoffset":10544,"anchor":"Future_directions"},{"toclevel":1,"level":"2","line":"External links","number":"6","index":"6","fromtitle":"Federation_of_European_Pharmacological_Societies","byteoffset":11252,"anchor":"External_links"},{"toclevel":1,"level":"2","line":"References","number":"7","index":"7","fromtitle":"Federation_of_European_Pharmacological_Societies","byteoffset":12290,"anchor":"References"}],"parsewarnings":[],"displaytitle":"Federation of European Pharmacological Societies","iwlinks":[],"properties":[{"name":"wikibase_item","*":"Q17155652"}]}}